Subject Index
∆^8 -THC
see∆^8 -tetrahydrocannabinol
∆^9 -THC
see∆^9 -tetrahydrocannabinol
∆5 fatty acid desaturase 286
∆6 fatty acid desaturase 286
∆6 fatty acid elongase 286
∆^8 -tetrahydrocannabinol
(∆^8 -THC, THC) 8, 16, 17
∆^9 -tetrahydrocannabinol
(∆^9 -THC, THC) 2, 3, 8,
13, 16, 17, 31–36, 54, 235,
284,293,527,540,574,578–
583, 585, 600, 601, 603–606,
608,614,616–618,659–683,
703–709, 722–744, 746–749
(–)-∆^8 -THC
see∆^8 -tetrahydrocannabinol
(–)-∆^9 -THC
see∆^9 -tetrahydrocannabinol
[^11 C]raclopride 438
[^123 I]AM251 7, 434
[^123 I]IBZM 430, 438
[^14 C] 2-deoxyglucose ([^14 C]2-DG)
428, 429
[^18 F]THC 430
[^18 F]fluorodeoxyglucose 430
[^35 S]GTPγS 9, 10, 24, 28, 29
[^3 H]BAY 38-7271 7
[^3 H]CP55940 7
[^3 H]HU-210 7
[^3 H]SR141716A 7
[^3 H]R-(+)-WIN55212 7
[^3 H]noradrenaline 344
[^3 H]noradrenaline release 346
1,2-diacylglycerol (DAG) 288
2-arachidonoyl glycerol (2-AG) 5,
6, 8, 14, 16, 17, 32–36, 55,
149, 188, 196, 284, 287–289,
293, 294, 368, 375, 574, 576,
582, 585, 586, 588–591, 600,
603, 607
biosynthesis of 150
metabolism of 159, 160
2-arachidonylglyceryl ether (noladin
ether) 5, 6, 8, 15, 20, 55,
196, 574, 576
2-palmitoylglycerol 196
5-HT 2 receptor 35
5-HT 3 receptor 35,36,310,330,734AA-5-HT 192
abnormal-cannabidiol receptor(s)
33–35, 37
abnormal-cannabidiol 19, 33,
34, 601, 605, 607–610, 612,
614
O-1918 34, 610–612
Acanthamoeba 400, 401
ACEA 8, 15, 18, 19
acetylcholine 342, 343, 347, 351,
574, 575, 583, 588
acid secretion 573, 587
ACPA 8, 15, 18, 34
acquired immune deficiency
syndrome (AIDS) 403–
405, 735
adenosine A 1 receptors 22
adenylate cyclase (adenylyl cyclase)
3, 4, 29, 56
adrenal medulla 346
adrenocorticotrophichormone 561